Authors: Del Mastro, L Venturini, M Lionetto, R Carnino, F Guarneri, D Gallo, L Contu, A Pronzato, P Vesentini, L Bergaglio, M Comis, S Rosso, R

Citation: L. Del Mastro et al., Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: Resultsof a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group, J CL ONCOL, 19(8), 2001, pp. 2213-2221

Authors: Falcone, A Di Paolo, A Masi, G Allegrini, G Danesi, R Lencioni, M Pfanner, E Comis, S Del Tacca, M Conte, P

Citation: A. Falcone et al., Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients, J CL ONCOL, 19(15), 2001, pp. 3456-3462

Authors: Garufi, G Dogliotti, L D'Attino, RM Tampellini, M Aschelter, AM Pugliese, P Perrone, M Nistico, C Comis, S Terzoli, E

Citation: G. Garufi et al., Irinotecan and chronomodulated infusion of 5-fluorouracil and folinic acidin the treatment of patients with advanced colorectal carcinoma - A phase I study, CANCER, 91(4), 2001, pp. 712-720

Authors: Comella, P Casaretti, R De Vita, F Avallone, A Orditura, M Petrillo, A Gravina, A Faranda, A Comis, S Comella, G Catalano, G

Citation: P. Comella et al., Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma:A phase I study of the Southern Italy Cooperative Oncology Group, ANN ONCOL, 10(8), 1999, pp. 915-921